Literature DB >> 981265

Simultaneous bilateral pyeloplasties.

H B Eckstein, D P Drake.   

Abstract

A technique is described which gives excellent results in the treatment of unilateral hydronephorsis and allows for simultaneous bilateral pyeloplasties. The advantages for the patients with bilateral hydronephrosis are a single admission to hospital and a single anaesthetic and operative procedure. The exposure is superior to that achieved by a loin incision, allowing the surgeon to perform the pyeloplasties more rapidly and with less traction on the renal vessels. Over a follow-up period of 1-7 years no subsequent pyeloplasty or nephrectomy has been required and all 11 patients are well and symptom free.

Entities:  

Mesh:

Year:  1976        PMID: 981265      PMCID: PMC1864595     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


  2 in total

1.  Hydronephrosis in children; a clinical study of seventy-eight cases with special reference to the role of aberrant renal vessels and the results of conservative operations.

Authors:  H H NIXON
Journal:  Br J Surg       Date:  1953-05       Impact factor: 6.939

2.  Hydronephrosis due to pelvi-ureteric obstruction in the newborn.

Authors:  D I Williams; C M Karlaftis
Journal:  Br J Urol       Date:  1966-04
  2 in total
  3 in total

1.  Robot-assisted bilateral simultaneous pyeloplasty: safe and feasible.

Authors:  Girdhar S Bora; DurgaPrasad Bendapudi; Ravimohan S Mavuduru; Santosh Kumar; Sudheer K Devana; Shrawan K Singh; Arup K Mandal
Journal:  J Robot Surg       Date:  2016-07-30

2.  Management of severe bilateral ureteropelvic junction obstruction in neonates with prenatally diagnosed bilateral hydronephrosis.

Authors:  Jongwon Kim; Sungwoo Hong; Chang Hoo Park; Hongzoo Park; Kun Suk Kim
Journal:  Korean J Urol       Date:  2010-09-17

3.  Postnatal management of bilateral Grade 3-4 ureteropelvic junction obstruction.

Authors:  Ramesh Babu; Ashay Rajnikant Suryawanshi; Utsav Shailesh Shah; Ashitha K Unny
Journal:  Indian J Urol       Date:  2020-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.